Metraipolis › archive › dc_fac7f0707442

Macrophage phagocytosis checkpoints in DLBCL immunotherapy: an evidence-maturity framework from CD47 to CD200 — Europe PMC PMID:42798844

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42798844
DOI
10.3389/fonc.2026.1933140
License (as archived)
solo-consultazione
Archived
2026-10-10T03:29:23.958Z
SHA-256 of the archived text
2333dc5dbcafa2f4358bce24733c9439d67bcee9de7f4af0cc0bcdd86f30ebc3
Stable URL of this page
https://metraipolis.com/documento/dc_fac7f0707442

How to cite

Macrophage phagocytosis checkpoints in DLBCL immunotherapy: an evidence-maturity framework from CD47 to CD200 — Europe PMC PMID:42798844 — Europe PMC (en), https://europepmc.org/article/MED/42798844 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fac7f0707442 (Metraipolis archive dc_fac7f0707442, sha256 2333dc5dbcafa2f4358bce24733c9439d67bcee9de7f4af0cc0bcdd86f30ebc3)
BibTeX
@misc{dcfac7f0707442,
  title = {Macrophage phagocytosis checkpoints in DLBCL immunotherapy: an evidence-maturity framework from CD47 to CD200 — Europe PMC PMID:42798844},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42798844},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fac7f0707442; sha256 2333dc5dbcafa2f4358bce24733c9439d67bcee9de7f4af0cc0bcdd86f30ebc3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42798844. Agents can read the archived copy with the MCP tool read_document.